Latest Content

Cogent submitted an FDA application for bezuclastinib after the phase 3 PEAK trial shows improved progression-free survival in patients with previously treated GIST.

Although I know better, I gardened in a sleeveless shirt and ended up with a poison ivy rash on my lymphedema limb. This time, I was lucky. Hopefully I will follow my own advice and avoid tempting fate next time.

Nurse Bridget Hopkins shares how she navigates metastatic breast cancer through second opinions, "YOLO" trips and the power of advanced care planning.

The phase 3 EMERALD-3 trial shows Imfinzi and Imjudo plus Lenvima and embolization improved progression-free survival in unresectable liver cancer.

The FDA fully approved Tecartus for adult patients with relapsed or refractory mantle cell lymphoma based on high response rates in the ZUMA-2 trial.

A new study shows Signatera ctDNA testing may identify older patients with ER+/HER2- breast cancer who can manage their care without invasive surgery.

A study found blood-based genomic testing can be completed in 27 hours, giving patients with cancer faster treatment decisions.

Eleven years with Stage 4 breast cancer, all on the first line of treatment. It isn’t chronic, but what is it?

Multiple myeloma survivor JP Kealy and wife Annamarie share how to avoid cancer burnout and why this journey is a marathon, not a sprint.

A couple opens up about navigating cancer care, advocating for themselves and balancing caregiver responsibilities with self-care.

New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients with lung cancer.

Author and multiple myeloma survivor Jonathan Gluck shares how an unexpected diagnosis reshaped his identity and approach to living with uncertainty.

The 49th Annual Miami Breast Cancer Conference recently hosted a cornerstone event for the advocacy community: the CURE Educated Patient® Breast Cancer Summit.